ACM Research, Inc. ACMR
Set alert
44.15 USD -1.32 -2.90%
At close
44.01 -0.14 -0.32%
Pre-market · Nov 3, 4:01 AM ET
43.60 Day range 47.31
28.46 52-week range 127.19
- YTD
- +11.91%
- 1 year
- +6.49%
- Open
- 46.55
- Prev close
- 45.47
- Mkt cap
- 3.08B
- Vol
- 1.15M
- Avg vol
- 1.07M
- EPS
- 2.12
- P/E
- 20.83
- Div yield
- 0.00%
More statistics
- Low
- 43.60
- High
- 47.31
- Forward P/E
- 15.01
- Beta
- 2.23
- Short ratio
- 2.60
- Inst. own
- 82.48%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 68.48
- 200-d avg
- 68.60
- 1y target
- 115.33
MAX chart
Events in this range
- Mar 24, 2022Split: 3 for 1
- Feb 28, 2025Rating: JP Morgan · — → Overweight
- Aug 6, 2025Earnings: 0.54; estimate 0.42; surprise 28.57%
- Sep 30, 2025Rating: Roth Capital · Buy → Buy
- Nov 5, 2025Earnings: 0.36; estimate 0.47; surprise -23.4%
- Feb 26, 2026Earnings: 0.25; estimate 0.39; surprise -35.9%
- May 5, 2026Rating: Seaport Global · — → Buy
- May 7, 2026Earnings: 0.34; estimate 0.255; surprise 33.33%
- Jun 18, 2026Rating: Roth Capital · Buy → Buy
- Jun 24, 2026Rating: Morgan Stanley · Overweight → Overweight
- Aug 7, 2026Earnings: 0.61; estimate 0.4186; surprise 45.72%
- Aug 26, 2026Rating: Daiwa Capital · — → Buy
- Nov 5, 2026Earnings: —; estimate 0.505; surprise —%
Signals (181)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bullish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| RSI: Overbought | Jun 8, 2026 | 4 months ago |
| RSI: Overbought | May 25, 2026 | 5 months ago |
| MACD: Buy Signal | May 11, 2026 | 5 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| SMA: Bearish | Mar 23, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| RSI: Overbought | Jan 26, 2026 | 9 months ago |
| RSI: Overbought | Jan 5, 2026 | 10 months ago |
| MACD: Buy Signal | Dec 22, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 10, 2025 | 11 months ago |
Newest 20 of 181.
Financial health
Altman Z-Score
3.19 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-3 / 5 overall
- DCF 3
- Return on Equity 3
- Return on Assets 3
- Debt / Equity 3
- P/E 1
- P/B 2
Valuation
P/E 26.8×
FY 2016 5y median 15.1× FY 2025
P/S 2.8×
FY 2016 5y median 2.1× FY 2025
P/B 1.7×
FY 2016 5y median 1.5× FY 2025
P/FCF -38.0×
FY 2016 5y median -8.4× FY 2025
EV/EBITDA 13.1×
FY 2016 5y median 8.6× FY 2025
EV/Sales 2.3×
FY 2016 5y median 2.0× FY 2025
FCF Yield -2.6%
FY 2016 5y median -3.0% FY 2025
Profitability
Gross Margin 44.4%
FY 2016 5y median 47.2% FY 2025
Operating Margin 12.1%
FY 2016 5y median 15.2% FY 2025
Net Margin 10.4%
FY 2016 5y median 13.2% FY 2025
ROE 6.4%
FY 2016 5y median 6.4% FY 2025
ROIC 4.4%
FY 2016 5y median 4.9% FY 2025
ROA 3.3%
FY 2016 5y median 3.6% FY 2025
Growth (YoY)
Revenue 15.2%
FY 2016 FY 2025
Operating Income -27.5%
FY 2016 FY 2025
EPS (diluted) -10.5%
FY 2016 FY 2025
Free Cash Flow -195.2%
FY 2016 FY 2025
Financial Health
Current Ratio 3.3×
FY 2016 5y median 2.4× FY 2025
Quick Ratio 2.3×
FY 2016 5y median 1.4× FY 2025
Debt / Equity 0.2×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -2.9×
FY 2016 5y median -2.3× FY 2025
Interest Coverage 15.7×
FY 2016 5y median 35.7× FY 2025
Dividends
Dividend Yield 0.3%
FY 2016 5y median 0.3% FY 2025
Payout Ratio 8.1%
FY 2016 5y median 5.1% FY 2025
Annual · latest fiscal year ends 2025-12-31
